Joseph Marcotrigiano

Title: The Innovations of Joseph Marcotrigiano

Introduction

Joseph Marcotrigiano is a distinguished inventor based in New Brunswick, NJ, renowned for his contributions to biochemistry and immunology. With a commendable portfolio of six patents, he has significantly advanced the understanding and application of antigen-specific B cells.

Latest Patents

Among Marcotrigiano's latest innovations are his patents related to compositions and methods for identifying and sorting antigen-specific B cells. These disclosures focus on constructs useful in expressing biotinylated monomers and tetramers derived from these monomers. Specifically, he provides constructs that express biotinylated antigen monomers, featuring viral proteins from the ectodomain of the Hepatitis C Virus (HCV) envelope glycoprotein E2 or Human Immunodeficiency Virus (HIV) gp140. His methodologies enhance the identification and isolation of antigen-specific B cells and facilitate cloning antibodies, marking a significant advancement in therapeutic applications.

Career Highlights

Joseph Marcotrigiano has had a notable career, working at prestigious institutions such as The Rockefeller University and Emory University. His work has been instrumental in both academic and research settings, contributing to innovations that bridge laboratory research and practical applications in medicine.

Collaborations

Throughout his career, Marcotrigiano has collaborated with esteemed colleagues such as Arash Grakoui and Stephen K. Burley. These partnerships have fostered an environment of innovation and creativity, further propelling advancements in the fields of immunology and biochemistry.

Conclusion

Joseph Marcotrigiano's impressive record of patents and collaborations underscores his pivotal role in the scientific community. His innovations not only contribute to academic knowledge but also pave the way for future advancements in the identification and treatment of diseases, showcasing the profound impact of his work on the field.